Pacritinib protects dendritic cells more efficiently than ruxolitinib.
Experimental hematology
View this publicationExperimental hematology
View this publicationScientific reports
View this publicationJournal of nuclear medicine : official publication, Society of Nuclear Medicine
View this publicationPharmacology & therapeutics
View this publicationHuman genetics
View this publicationZentralblatt fur Chirurgie
View this publicationInternational journal of dermatology
View this publicationCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
View this publicationJournal of the American Society of Nephrology : JASN
View this publicationAllergo journal international
View this publication